Kohmei Kubo

Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis.

Junichi Okutsu, Tatsuhiko Tsunoda, Yasuyuki Kaneta et al. · PubMed · 2002 · 80 citations

Medicine, Cancer Biology, Oncology +17

Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry

Koji Nagafuji, Keitaro Matsuo, Takanori Teshima et al. · International Journal of Hematology · 2010 · 51 citations

Medicine, Hematology, Oncology +17

Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia

Yoji Ishida, Kazunori Murai, Kohei Yamaguchi et al. · European Journal of Clinical Pharmacology · 2015 · 50 citations

Medicine, Pharmacokinetics, Pharmacology +6

A randomized, double‐blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during <scp>CHASE</scp>(R) chemotherapy for malignant lymphoma

Kohmei Kubo, Yasuhiko Miyazaki, Tohru Murayama et al. · British Journal of Haematology · 2016 · 45 citations · Full text

Medicine, Hematology, Oncology +17

Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study

Atsushi Wakita, Shigeki Ohtake, Satoru Takada et al. · International Journal of Hematology · 2012 · 36 citations · Full text

Medicine, Geriatric Medicine, Oncology +11